These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19855377)

  • 1. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer.
    Thike AA; Cheok PY; Jara-Lazaro AR; Tan B; Tan P; Tan PH
    Mod Pathol; 2010 Jan; 23(1):123-33. PubMed ID: 19855377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
    Collins LC; Martyniak A; Kandel MJ; Stadler ZK; Masciari S; Miron A; Richardson AL; Schnitt SJ; Garber JE
    Am J Surg Pathol; 2009 Jul; 33(7):1093-7. PubMed ID: 19390427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship.
    Thike AA; Iqbal J; Cheok PY; Tse GM; Tan PH
    J Clin Pathol; 2013 Aug; 66(8):665-70. PubMed ID: 23539741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters.
    Chen MH; Yip GW; Tse GM; Moriya T; Lui PC; Zin ML; Bay BH; Tan PH
    Mod Pathol; 2008 Oct; 21(10):1183-91. PubMed ID: 18536655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-negative breast cancer: current state of the art.
    Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
    Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes.
    Niwińska A; Olszewski W; Murawska M; Pogoda K
    J Neurooncol; 2011 Dec; 105(3):547-53. PubMed ID: 21656328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A; Sussman ZM; Lawson D; Cohen C
    Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast.
    Marginean F; Rakha EA; Ho BC; Ellis IO; Lee AH
    Mod Pathol; 2010 Oct; 23(10):1357-63. PubMed ID: 20581807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.
    Niemeier LA; Dabbs DJ; Beriwal S; Striebel JM; Bhargava R
    Mod Pathol; 2010 Feb; 23(2):205-12. PubMed ID: 19898421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
    Cheang MC; Voduc D; Bajdik C; Leung S; McKinney S; Chia SK; Perou CM; Nielsen TO
    Clin Cancer Res; 2008 Mar; 14(5):1368-76. PubMed ID: 18316557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
    Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
    Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype.
    Titloye NA; Foster A; Omoniyi-Esan GO; Komolafe AO; Daramola AO; Adeoye OA; Adisa AO; Manoharan A; Pathak D; D'Cruz MN; Alizadeh Y; Lewis PD; Shaaban AM
    Pathobiology; 2016; 83(1):24-32. PubMed ID: 26730581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).
    Lerma E; Peiro G; Ramón T; Fernandez S; Martinez D; Pons C; Muñoz F; Sabate JM; Alonso C; Ojeda B; Prat J; Barnadas A
    Mod Pathol; 2007 Nov; 20(11):1200-7. PubMed ID: 17885672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.
    Thike AA; Iqbal J; Cheok PY; Chong AP; Tse GM; Tan B; Tan P; Wong NS; Tan PH
    Am J Surg Pathol; 2010 Jul; 34(7):956-64. PubMed ID: 20495445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
    Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
    PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
    Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
    Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic markers in triple-negative breast cancer.
    Rakha EA; El-Sayed ME; Green AR; Lee AH; Robertson JF; Ellis IO
    Cancer; 2007 Jan; 109(1):25-32. PubMed ID: 17146782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple negative breast cancers: clinical and prognostic implications.
    Dawson SJ; Provenzano E; Caldas C
    Eur J Cancer; 2009 Sep; 45 Suppl 1():27-40. PubMed ID: 19775602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.